Bavarian Nordic has secured a DKK 200 million+ vaccine contract in Europe, bringing total public‑preparedness deals to over ...

Neuschwanstein Castle and three other royal residences built by King Ludwig II of Bavaria have been designated as UNESCO ...

Despite Africa bearing the brunt of infections and deaths, wealthy nations continue stockpiling Jynneos vaccine ...

Recurring order from an undisclosed European country to strengthen public preparedness.Combined with other recent orders from non-European countries, the Company has now secured above DKK 3,000 millio ...

Recurring order from an undisclosed European country to strengthen public preparedness.Combined with other recent orders from ...

Vaccine supply shortage comes at a bad time, as African countries make headway with their outbreaks and have seen good uptake ...

Review quarterly and annual revenue, net income, and cash flow for Bavarian Nordic AS (BAVA:XCSE) stock through the last fiscal year.

Monkeypox Vaccine and Treatment revenue is expected to grow at a CAGR of 10.20% from 2025 to 2032, reaching nearly USD 225.12 Mn by 2032.